•
Sep 30, 2023

Avidity Biosciences Q3 2023 Earnings Report

Total Revenue
$2.82M
Previous year: $2.48M
+13.5%
EPS
-$0.71
Previous year: -$0.82
-13.4%
Gross Profit
$1.52M
Previous year: $2.08M
-27.1%
Cash and Equivalents
$543M
Previous year: $144M
+277.6%
Free Cash Flow
-$37.7M
Previous year: -$31.9M
+18.4%
Total Assets
$573M
Previous year: $431M
+33.1%

Avidity Biosciences

Avidity Biosciences

Avidity Biosciences Revenue by Segment